Cardiovascular Health Metrics Differ Between Individuals With and Without Cancer

Ofer Kobo1,2, Dmitry Abramov3, Manuela Fiuza4

  • 1Department of Cardiology Hillel Yaffe Medical Center Hadera Israel.

Insights

Individuals with cancer have lower cardiovascular health (CVH) scores but better key behaviors like physical activity and diet. These findings highlight disparities and inform strategies for improving CVH in cancer patients.

Area of Science:

  • Cardiology
  • Oncology
  • Public Health

Background:

  • Cancer survivors face high rates of cardiovascular disease.
  • Limited data exist on cardiovascular health (CVH) differences between cancer patients and the general population.

Purpose of the Study:

  • To compare CVH metrics between US adults with and without a cancer history.
  • To analyze CVH score variations based on demographics like age, sex, race, ethnicity, and socioeconomic status.

Main Methods:

  • Utilized data from the National Health and Nutrition Examination Survey (2015-2020).
  • Assessed the American Heart Association's Life's Essential 8 construct for CVH.
  • Analyzed health metric prevalence and scores in 4370 adult participants, including 9.4% with a cancer history.

Main Results:

  • Individuals with cancer had significantly lower overall CVH scores (67.1 vs. 69.1, P<0.001).
  • Cancer patients demonstrated better scores in physical activity, diet, and sleep behaviors.
  • These behavioral improvements were more pronounced in older, White, and higher socioeconomic status individuals.

Conclusions:

  • Significant variations exist in CVH metrics between cancer patients and non-cancer individuals.
  • Demographic factors (age, race, ethnicity, socioeconomic status) influence these CVH differences.
  • Findings provide a framework for optimizing cardiovascular care in the cancer population and addressing health disparities.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
343
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
167
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
356
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
96
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
265